CURATIS HOLDING AG

Curatis slips 5% as thin liquidity and stalled R&D shake investor confidence—CHF 17.45 offers a risky discount versus a CHF 20.64 200‑day average.

Curatis (CURN.SW) rises 1.45% to CHF 17.45, after an 8.88% monthly dip. Discover its market cap, recent trends, and how it stacks against peers.

Curatis shares hold steady amid market dip, trading above its 200‑day average with a promising therapeutic pipeline and disciplined valuation—an attractive entry for long‑term investors.